Hillman Cancer Ctr., University of Pittsburgh — Pittsburgh, Pennsylvania

Hillman Cancer Ctr., University of Pittsburgh is a clinical research site located in Pittsburgh, Pennsylvania, United States 15213.

Crixeo Clinical Trials Trust Score: 94/100 (GOOD). This profile has not yet been claimed by the site owner.

Hillman Cancer Ctr., University of Pittsburgh has participated in 1 clinical trials.

Therapeutic areas: Cutaneous T-cell Lymphoma (CTCL),.

Sponsors: BioCryst Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pittsburgh

Browse all research sites in Pennsylvania · View every site in Pittsburgh

Sponsor Feasibility Report

Trust Score: 94/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hillman Cancer Ctr., University of Pittsburgh?

Hillman Cancer Ctr., University of Pittsburgh has a Crixeo Trust Score of 94/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hillman Cancer Ctr., University of Pittsburgh conducted?

Hillman Cancer Ctr., University of Pittsburgh has 1 clinical trials on record. Their work covers Cutaneous T-cell Lymphoma (CTCL),.

Is Hillman Cancer Ctr., University of Pittsburgh accredited by Crixeo Clinical Trials?

Hillman Cancer Ctr., University of Pittsburgh has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hillman Cancer Ctr., University of Pittsburgh?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.